Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine/nab-paclitaxel chemotherapy in resected …

FI Macedo, E Ryon, SK Maithel, RM Lee… - Annals of …, 2019 - journals.lww.com
Objective: To compare the survival outcomes associated with clinical and pathological
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …
被引用次数：136 相关文章

Survival Outcomes Associated with Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in …

FI Macedo, E Ryon, SK Maithel, RM Lee… - Annals of …, 2019 - profiles.wustl.edu
Objective: To compare the survival outcomes associated with clinical and pathological
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …
[HTML] nih.gov

[HTML][HTML] Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy …

FI Macedo, E Ryon, SK Maithel, RM Lee… - Annals of …, 2019 - ncbi.nlm.nih.gov
Objective: To compare the survival outcomes associated with clinical and pathological
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in …

FI Macedo, E Ryon, SK Maithel, RM Lee… - Annals of …, 2019 - europepmc.org
Objective To compare the survival outcomes associated with clinical and pathological
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …

[引用][C] Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in …

FI Macedo, E Ryon, SK Maithel, RM Lee, DA Kooby… - Annals of …, 2019 - cir.nii.ac.jp
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant
FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer …

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in …

FI Macedo, E Ryon, SK Maithel, RM Lee… - Annals of …, 2019 - scholarship.miami.edu
Abstract Leucovorin-administration & dosage Multivariate Analysis Antineoplastic Combined
Chemotherapy Protocols-administration & dosage Prognosis Humans Middle Aged Male …

Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in …

FI Macedo, E Ryon, SK Maithel, RM Lee… - Annals of …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective To compare the survival outcomes associated with clinical and pathological
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …